Search - tctmd.com

Displaying 821 - 840 of 892

Sort: Relevancy | Date

News Daily News

La PCI Multivaso es Mejor que la PCI solo Causante en Pacientes STEMI en Shock y Parada Cardíaca

Yael L. Maxwell

February 12, 2013

Presentation TCT 2013

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Presenter: Shin Eun Lee, Myung Ho Jeong, Young Jo Kim, Dong Yub Lee, Seong Jung Park

January 31, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

Presentation AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Presenter: Weon Kim

November 04, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Daily News

French Registry: Women with STEMI Fare Worse Than Male Counterparts

October 23, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Meta-analysis: PCI Beats Medical Therapy for Angina Relief but Little Else in Stable CAD

Jason Kahn

August 14, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

Advertisement

La PCI Multivaso es Mejor que la PCI solo Causante en Pacientes STEMI en Shock y Parada Cardíaca

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

French Registry: Women with STEMI Fare Worse Than Male Counterparts

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Meta-analysis: PCI Beats Medical Therapy for Angina Relief but Little Else in Stable CAD

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content